BeStock  
Stocks › Biotechnology › IONS

Ionis Pharmaceuticals IONS

US equityMarket cap rank #2142Biotechnology
$26.58 −$0.64 (-2.35%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.76 +0.68%
Open$26.93
Prev close$27.22
Day range$26.53 – $28.07
Volume3.19M
Market cap$4.43B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±4.0%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+4.6%
Worst reaction-21.4%

Stock move on the day after each report

-1.8%2023/Q4-3.2%2024/Q1+3.8%2024/Q2+0.6%2024/Q3-0.4%2024/Q4+3.0%2025/Q1+4.6%2025/Q2-2.3%2025/Q3-5.3%2025/Q4+4.2%2026/Q1-2.3%2026/Q2-21.4%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q39 Nov 2026Pre Market±11.7%-21.36%Bigger than priced
2026/Q229 Jul 2026Pre Market±8.2%-2.28%Within range
2026/Q129 Apr 2026Pre Market±5.5%+4.25%Within range
2025/Q425 Feb 2026Pre Market±9.2%-5.29%Within range
2025/Q329 Oct 2025Pre Market±10.9%-2.30%Within range
2025/Q230 Jul 2025None±10.7%+4.56%Within range
2025/Q130 Apr 2025None±12.8%+3.02%Within range
2024/Q419 Feb 2025None±9.9%-0.44%Within range
2024/Q36 Nov 2024None±7.1%+0.62%Within range
2024/Q21 Aug 2024Pre Market±7.2%+3.76%Within range
2024/Q17 May 2024None±6.7%-3.19%Within range
2023/Q421 Feb 2024Pre Market±10.2%-1.85%Within range
2023/Q32 Nov 2023Pre Market±9.2%-3.38%Within range
2023/Q29 Aug 2023Pre Market±7.2%+1.11%Within range
2023/Q13 May 2023None±9.2%-2.22%Within range
2022/Q422 Feb 2023None±9.4%-3.74%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$242.72M+54.9% YoY
Operating profit-$130.68M+18.4% YoY
Net profit-$109.97M+14.5% YoY
Diluted EPS-$0.66+17.5% YoY
Free cash flow-$193.63M-39.9% YoY
Operating cash flow-$179.42M

Revenue, last 8 quarters

$226.6MDec '24$131.6MMar '25$452.0MJun '25$156.7MSep '25$203.3MDec '25$246.1MMar '26$267.9MJun '26$242.7MSep '26

Net profit, last 8 quarters

$-104.3MDec '24$-146.9MMar '25$123.6MJun '25$-128.6MSep '25$-229.4MDec '25$-92.5MMar '26$-114.6MJun '26$-110.0MSep '26

Profitability & balance sheet

Gross margin98.2%
Operating margin-58.8%
Net margin-56.9%
Return on equity-108.1%
Return on assets-18.4%
Return on invested capital-24.5%
Current ratio5.43
Liabilities / assets86.5%
Cash & investments$1.88B
Total debt$1.63B
Net cash (debt)$254.72M

Discussion

No comments yet — be the first to weigh in on IONS.

Sign in to join the discussion.

Scroll to Top